The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

The National Biotechnology Research and Development Agency (NBRDA) has said biotechnology is more relevant than ever, ...

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax efficient and ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

KKR & Co.-backed venture capital firm Catalio Capital Management gathered more than $400 million for its latest fund, a ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...

The NATO Innovation Fund has made its first investment in a biotechnology company, it said on Monday, seeking to enhance ...